EMADINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Emadine, and what generic alternatives are available?
Emadine is a drug marketed by Novartis and is included in one NDA.
The generic ingredient in EMADINE is emedastine difumarate. There is one drug master file entry for this compound. Additional details are available on the emedastine difumarate profile page.
Summary for EMADINE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 58 |
Patent Applications: | 2,148 |
Drug Prices: | Drug price information for EMADINE |
DailyMed Link: | EMADINE at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for EMADINE
US Patents and Regulatory Information for EMADINE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Novartis | EMADINE | emedastine difumarate | SOLUTION/DROPS;OPHTHALMIC | 020706-001 | Dec 29, 1997 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for EMADINE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Novartis | EMADINE | emedastine difumarate | SOLUTION/DROPS;OPHTHALMIC | 020706-001 | Dec 29, 1997 | ⤷ Try a Trial | ⤷ Try a Trial |
Novartis | EMADINE | emedastine difumarate | SOLUTION/DROPS;OPHTHALMIC | 020706-001 | Dec 29, 1997 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for EMADINE
See the table below for patents covering EMADINE around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
South Korea | 100275016 | ⤷ Try a Trial | |
Greece | 3032264 | ⤷ Try a Trial | |
Japan | H0224821 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |